UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma Journal article
Zhang, Qi Yi, Ding, Wen, Mo, Jian Shan, Ou-yang, Shu Min, Lin, Zi You, Peng, Ke Ren, Liu, Guo Pin, Lu, Jin Jian, Yue, Pei Bin, Lei, Jin Ping, Wang, Yan Dong, Zhang, Xiao Lei. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma[J]. ACTA PHARMACOLOGICA SINICA, 2024.
Authors:  Zhang, Qi Yi;  Ding, Wen;  Mo, Jian Shan;  Ou-yang, Shu Min;  Lin, Zi You; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:6.9/7.6 | Submit date:2024/05/16
Acquired Sorafenib-resistance  Antisense Oligonucleotide  Hepatocellular Carcinoma  Stat3  
An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease Journal article
Huang Z., Gan J., Jia L., Guo G., Wang C., Zang Y., Ding Z., Chen J., Zhang J., Dong L.. An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease[J]. Biomaterials, 2015, 48, 26.
Authors:  Huang Z.;  Gan J.;  Jia L.;  Guo G.;  Wang C.; et al.
Favorite | TC[WOS]:63 TC[Scopus]:72 | Submit date:2018/10/30
Antisense Oligonucleotide  Colonic Macrophages  Inflammatory Bowel Disease  Targeting Delivery  Tnf-α  
Antisense oligonucleotide targeting TNF-α can suppress Co-Cr-Mo particle-induced osteolysis Journal article
Dong L., Wang R., Zhu Y.-A., Wang C., Diao H., Zhang C., Zhao J., Zhang J.. Antisense oligonucleotide targeting TNF-α can suppress Co-Cr-Mo particle-induced osteolysis[J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2008, 26(8), 1114-1120.
Authors:  Dong L.;  Wang R.;  Zhu Y.-A.;  Wang C.;  Diao H.; et al.
Favorite | TC[WOS]:30 TC[Scopus]:35  IF:2.1/2.9 | Submit date:2018/11/07
Antisense Oligonucleotide  Osteoclastogenesis  Particle-induced Osteolysis  Tnf-α